Long-term Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rate in the Middle East and North Africa: a Systematic Review and Meta-analysis of 178 Population-Based Studies

Abstract

Purpose of ReviewThis study investigated and pooled the long-term trends in prevalence, awareness, treatment, and control of hypertension (HTN) in the Middle East and North Africa (MENA) region. In this systematic review and meta-analysis, we searched MEDLINE/PubMed, Web of Science, Google Scholar, EMBASE, and Scopus between database inception and November 2020. All cross-sectional studies that investigated the prevalence of pre-HTN, HTN, awareness, treatment, and control in the MENA counties were included. The selection study, data extraction, and quality assessment were conducted by two investigators independently. Heterogeneity between studies was assessed using Cochran's Q test and I-squared, and due to sever heterogeneity between studies, the random effect model was used to pool the estimates. Sensitivity analysis was performed to estimate the long-term trends in prevalence, awareness, treatment, and control rates of HTN according to definition of HTN as systolic blood pressure of 140 mm Hg or more, or diastolic blood pressure of 90 mm Hg or more, or being on pharmacological treatment for HTN. Recent Findings Overall, 178 studies met the inclusion criteria. Studies comprised 2,262,797 participants with a mean age of 45.72 ± 8.84 years. According to random effect model, the pooled prevalence of pre-HTN and HTN was 33% (95% CI 28, 39) and 26% (25, 27), respectively. Over the past three decades, prevalence of hypertension increased significantly in the region. The pooled awareness, treatment, and control rates were 50% (48, 53), 41% (38, 44), and 19% (17, 21), receptively. The pooled awareness, treatment, and control rates of HTN were lower significantly in men than women. According to definition of HTN as blood pressures above 140/90 mm Hg, over the past three decades, although the awareness and treatment rates did not change significantly, the control rates improved significantly in the region. Summary The findings showed that HTN is a significant public health problem in the MENA region. Although there are low levels of pooled awareness, treatment, and control rates, the control rates improved over the past three decades in the region.

Analysis of Hypertension in Peru: Prevalence, Associated Factors, Knowledge, Management and Control, 2014-2022

“…For controlled HTN, treatment adherence is crucial. In this aspect, factors like education level and social support play an essential role, similar to those observed in other countries (41–43) . The difficulty in controlling HTN despite treatment may be related to genetic factors, lifestyle, and the presence of concomitant diseases.…”

Prevalence, Awareness, Treatment, and Control of Hypertension among Adult Residents of Tehran: The Tehran Cohort Study

“…Hence, early initiation of pharmacologic therapy as indicated, single-pill regimens, and telehealth programs should be considered in these individuals to improve drug adherence and BP control [ 29 30 ]. A recent systematic review and meta-analysis pooling evidence from 107 national and subnational studies in Iran showed that the BP control rate varies from 4.5% to 68.39% between different geographical regions [ 31 ]. This highlights the importance of our region-specific findings among adult residents of Tehran, which is one of the largest metropolitan areas in the Middle East.…”

Burnout and Cardiovascular Risk in Healthcare Professionals During the COVID-19 Pandemic

“…The disparities in response distribution in our study, on the other hand, could point to a general distribution per category that is independent of the pandemic. For example, the fact that more men reported high blood pressure and smoking while more women reported low physical activity may reflect the well-known high prevalence of hypertension and smoking in men while women are more sedentary ( 40 , 41 ).…”